PRAMIPEXOL MYLAN 2.62mg prolonged tablets medication leaflet

N04BC05 pramipexole • Nervous system | Dopaminergic agents | Dopamine agonists

Pramipexole is a dopamine receptor agonist used for the treatment of Parkinson's disease and restless legs syndrome. It works by stimulating dopamine receptors in the brain, alleviating motor and non-motor symptoms.

The medication is taken orally, as directed by a doctor, usually once to three times daily. It is important for patients to follow the treatment regimen and inform the doctor about any other medications being used.

Patients should be aware of potential side effects, such as drowsiness, dizziness, or nausea. It is important to inform the doctor of any unusual symptoms.

Common side effects include drowsiness, dizziness, and nausea. In rare cases, severe reactions such as hallucinations or compulsive behaviors may occur. Patients should be informed of these risks before use.

General data about PRAMIPEXOL MYLAN 2.62mg

Substance: pramipexole

Date of last drug list: 01-06-2019

Commercial code: W65455005

Concentration: 2.62mg

Pharmaceutical form: prolonged tablets

Quantity: 100

Product type: generic

Prescription restrictions: P-RF - Medicines prescription that is retained in the pharmacy (not renewable).

Marketing authorisation

Manufacturer: GENERICS (UK) LTD. - MAREA BRITANIE

Holder: MYLAN S.A.S. - FRANTA

Number: 11089/2018/05

Shelf life: 3 years

Pharmaceutical forms available for pramipexole

Concentrations available for pramipexole

0.088mg, 0.18mg, 0.26mg, 0.35, 0.35mg, 0.52mg, 0.54mg, 0.70mg, 0.7mg, 1.05mg, 1.1mg, 1.57mg, 2.10mg, 2.1mg, 2.62mg, 3.15mg